Metabolic bone disease in inflammatory bowel disease

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Chronic inflammatory bowel diseases (IBD) affect bone metabolism and are frequently associated with decreased bone mineral density (BMD) and increased risk of fractures. Experimental models of IBD and as well as data from pediatric and adult IBD patients do not provide a uniform answer whether the changes in bone metabolism leading to decreased mineral density are the result of decreased bone formation, increased bone desorption, or both. New studies continue to unravel a complex network of interactions leading to the inflammation-associated loss of BMD, and may help direct treatment of IBD toward more bone-sparing strategies. Nutritional interventions (dietary calcium and vitamin D supplementation) are of limited efficacy in IBD patients. Therefore, appreciating the extent of the problem and understanding the pathophysiology of osteopenia and osteoporosis in Crohn's disease and ulcerative colitis are critical for the correct choice of available treatments or the development of new targeted therapies.

Original languageEnglish (US)
Pages (from-to)16-26
Number of pages11
JournalPractical Gastroenterology
Volume36
Issue number9
StatePublished - Sep 2012

Fingerprint

Metabolic Bone Diseases
Inflammatory Bowel Diseases
Bone and Bones
Bone Density
Dietary Calcium
Ulcerative Colitis
Osteogenesis
Vitamin D
Crohn Disease
Osteoporosis
Minerals
Theoretical Models
Therapeutics
Pediatrics
Inflammation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Metabolic bone disease in inflammatory bowel disease. / Ghishan, Fayez K; Kiela, Pawel R.

In: Practical Gastroenterology, Vol. 36, No. 9, 09.2012, p. 16-26.

Research output: Contribution to journalArticle

@article{e48ae8e7572d479ab554a699b9ef099c,
title = "Metabolic bone disease in inflammatory bowel disease",
abstract = "Chronic inflammatory bowel diseases (IBD) affect bone metabolism and are frequently associated with decreased bone mineral density (BMD) and increased risk of fractures. Experimental models of IBD and as well as data from pediatric and adult IBD patients do not provide a uniform answer whether the changes in bone metabolism leading to decreased mineral density are the result of decreased bone formation, increased bone desorption, or both. New studies continue to unravel a complex network of interactions leading to the inflammation-associated loss of BMD, and may help direct treatment of IBD toward more bone-sparing strategies. Nutritional interventions (dietary calcium and vitamin D supplementation) are of limited efficacy in IBD patients. Therefore, appreciating the extent of the problem and understanding the pathophysiology of osteopenia and osteoporosis in Crohn's disease and ulcerative colitis are critical for the correct choice of available treatments or the development of new targeted therapies.",
author = "Ghishan, {Fayez K} and Kiela, {Pawel R}",
year = "2012",
month = "9",
language = "English (US)",
volume = "36",
pages = "16--26",
journal = "Practical Gastroenterology",
issn = "0277-4208",
publisher = "Shugar Publishing Inc.",
number = "9",

}

TY - JOUR

T1 - Metabolic bone disease in inflammatory bowel disease

AU - Ghishan, Fayez K

AU - Kiela, Pawel R

PY - 2012/9

Y1 - 2012/9

N2 - Chronic inflammatory bowel diseases (IBD) affect bone metabolism and are frequently associated with decreased bone mineral density (BMD) and increased risk of fractures. Experimental models of IBD and as well as data from pediatric and adult IBD patients do not provide a uniform answer whether the changes in bone metabolism leading to decreased mineral density are the result of decreased bone formation, increased bone desorption, or both. New studies continue to unravel a complex network of interactions leading to the inflammation-associated loss of BMD, and may help direct treatment of IBD toward more bone-sparing strategies. Nutritional interventions (dietary calcium and vitamin D supplementation) are of limited efficacy in IBD patients. Therefore, appreciating the extent of the problem and understanding the pathophysiology of osteopenia and osteoporosis in Crohn's disease and ulcerative colitis are critical for the correct choice of available treatments or the development of new targeted therapies.

AB - Chronic inflammatory bowel diseases (IBD) affect bone metabolism and are frequently associated with decreased bone mineral density (BMD) and increased risk of fractures. Experimental models of IBD and as well as data from pediatric and adult IBD patients do not provide a uniform answer whether the changes in bone metabolism leading to decreased mineral density are the result of decreased bone formation, increased bone desorption, or both. New studies continue to unravel a complex network of interactions leading to the inflammation-associated loss of BMD, and may help direct treatment of IBD toward more bone-sparing strategies. Nutritional interventions (dietary calcium and vitamin D supplementation) are of limited efficacy in IBD patients. Therefore, appreciating the extent of the problem and understanding the pathophysiology of osteopenia and osteoporosis in Crohn's disease and ulcerative colitis are critical for the correct choice of available treatments or the development of new targeted therapies.

UR - http://www.scopus.com/inward/record.url?scp=84867539292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867539292&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84867539292

VL - 36

SP - 16

EP - 26

JO - Practical Gastroenterology

JF - Practical Gastroenterology

SN - 0277-4208

IS - 9

ER -